ACHILLES EXPRESS ULTRASONOMETER

FDA Premarket Approval P970040

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

The device is indicated as follows: the achilles+ultrasonometer measures ultrasound variables of the os calcis to provide a clinical measure called stiffness index. The stiffnes index indicateds risk of osteoporotic fracture in postmenopausal women comparable to bone mineral density (bmd) as measured by x-ray absorptiometry at teh spine or hip. Stiffness index results expressed as t-scores are used to assist the physicians in the diagnosis of osteoporosis in the same way as are t-scores or obtained by x-ray absorpiometry. Either the stiffness index t-score or x-ray absorptiometry t-score can be utilized by a physician, in conjunction with other clinical risk factors, to provide a comprehensive skeletal assessment. The stiffness index has a precision error in older women comparable to that of x-ray absorptiometry, which makes it suitable for moniotirng bone changes.

DeviceACHILLES EXPRESS ULTRASONOMETER
Generic NameBone Sonometer
ApplicantGE LUNAR CORP.
Date Received1997-09-02
Decision Date1998-06-26
Notice Date1998-10-07
PMAP970040
SupplementS
Product CodeMUA 
Docket Number98M-0715
Advisory CommitteeRadiology
Expedited ReviewNo
Combination Product No
Applicant Address GE LUNAR CORP. 726 Heartland Trail madison, WI 53717

Supplemental Filings

Supplement NumberDateSupplement Type
P970040Original Filing
S003 2004-07-15 Normal 180 Day Track No User Fee
S002 2001-05-07 Normal 180 Day Track
S001 1999-02-16 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.